# Investigation of the Response Relationship of NN5401 in Type 1 Diabetics

> **NCT00993096** · PHASE1 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 33 (actual)

## Conditions studied

- Diabetes
- Diabetes Mellitus, Type 1

## Interventions

- **DRUG:** insulin degludec/insulin aspart
- **DRUG:** insulin degludec/insulin aspart
- **DRUG:** insulin degludec/insulin aspart
- **DRUG:** biphasic insulin aspart 30
- **DRUG:** biphasic insulin aspart 30
- **DRUG:** biphasic insulin aspart 30

## Key facts

- **NCT ID:** NCT00993096
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2017-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00993096

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00993096, "Investigation of the Response Relationship of NN5401 in Type 1 Diabetics". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT00993096. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*